The challenge of scaling synthetic DNA from laboratory batches to production scale vaccine pipelines demands careful planning and robust processes. Synbio Technologies recognizes that efficient scale up depends on reliable DNA supply and flexible manufacturing. In vaccine research projects, early stages require small fragments, while eventual production may require longer constructs and …
